AstraZeneca Can't End Nexium Pay-For-Delay Trial
A Massachusetts federal judge on Monday refused to allow AstraZeneca PLC and Ranbaxy Inc. to end a pay-for-delay trial over the heartburn drug Nexium, saying the case should go before a...To view the full article, register now.
Already a subscriber? Click here to view full article